LONDON & HOUSTON--(BUSINESS WIRE)--The Focus ADHD program, created by objective testing provider Qbtech and the AHSN Network, received the Best Innovative Mental Health Invention at the 2022 National ...

HOUSTON--(BUSINESS WIRE)--As the Public Health Emergency (PHE) expires, it’s evident how far we have come in providing care and treatment, yet there is still substantial work to be done. Qbtech, Inc., ...

Use of Objective ADHD Testing Technology for Diagnosis and Treatment Monitoring Upskills Masters Level Clinicians and Enables Data-Driven Decision-Making Qbtech’s FDA-cleared objective testing ...

Addition of clinical research and strategic partnership teams marks another milestone for Qbtech in North America, bolstering the company’s regional capabilities and footprint HOUSTON, June 02, 2025-- ...

Sweden-based Qbtech has received an FDA 510(k) clearance for an online tool, called QbCheck, that offers clinical decision-making support for diagnosing and treating children with ADHD. According to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thanks to growth from an equity ...

Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: ...

Global Leader in ADHD Objective Testing Improves Access to Care for Patients in the U.S. and UK The National Institute for Clinical Excellence (NICE), a UK government-funded, non-departmental public ...

In response to the recent arrests of Done founder Ruthia He and clinical leader David Brody for the company's alleged stimulant prescription practices, Qbtech, the global leader in objective ADHD ...

The US Food and Drug Administration (FDA) has cleared the ADHD test-QbCheck-developed by the Swedish company Qbtech to aid in the assessment and evaluation of treatment interventions in patients with ...